Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases

Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases

For the past few years more and more new cytotoxic agents active in the treatment of hematological malignancies have been synthesized and become available for either in vitro studies or clinical trials. Among them the class of antineoplastic drugs belonging to the purine nucleoside analogues group (...

Full description

Bibliographic Details
Main Authors: Pawel Robak, Ewa Lech-Maranda, Tadeusz Robak, Anna Korycka
Format: Article
Language:English
Published: MDPI AG 2009-03-01
Series:Molecules
Subjects:
Fludarabine
Cladribine
Pentostatin
Clofarabine
Nelarabine
Forodesine
Purine nucleoside analogues
Mechanism of action
Clinical application
Online Access:http://www.mdpi.com/1420-3049/14/3/1183/

Internet

http://www.mdpi.com/1420-3049/14/3/1183/

Similar Items